Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ocumension Therapeutics | 5DG | May 31, 2024 | 0.78 | +0.65 |
Oncimmune Holdings plc | OCY | May 31, 2024 | 0.22 | -0.89 |
Oncoarendi Therapeutics SA | 1B1 | May 31, 2024 | 3.38 | -1.03 |
Oncotherpapy Science Inc | 30O | May 31, 2024 | 0.11 | -16.91 |
Open Orphan plc | CRO | May 31, 2024 | 0.30 | +0.68 |
Opthea Limited | UKJ | May 31, 2024 | 0.28 | -4.11 |
OptiBiotix Health plc | OB3 | May 31, 2024 | 0.21 | 0.00 |
Oric Pharmaceuticals, Inc. | 4TZ | May 31, 2024 | 8.40 | +7.01 |
Oxford BioDynamics plc | LMQ | May 31, 2024 | 0.05 | +2.04 |
Oxford Biomedica | OXOA | May 31, 2024 | 3.72 | +2.76 |
Pharmaron Beijing Co Ltd | 17Q1 | May 31, 2024 | 1.08 | +3.85 |
Pharmaust Ltd. | ECQ | May 31, 2024 | 0.10 | -6.60 |
Philogen S.p.a. | 78Q | May 31, 2024 | 20.20 | +1.76 |
Physiomics | RVW1 | May 31, 2024 | 0.01 | -11.11 |
Polynovo Limited | MFJ | May 31, 2024 | 1.34 | +2.29 |
Poseida Therapeutics, Inc. | 2RZ | May 31, 2024 | 2.59 | -0.61 |
Pure Biologics S A | PQB | May 31, 2024 | 1.36 | +0.15 |
PureTech Health Plc | 0VQ | May 31, 2024 | 2.70 | -3.57 |
Quantum Genomics | 2QG | May 31, 2024 | 0.10 | 0.00 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | May 31, 2024 | 0.33 | +0.62 |
RemeGen Co. Ltd. | REG | May 31, 2024 | 3.10 | +3.33 |
ReproCELL Incorporated | 6RC | May 31, 2024 | 0.56 | +3.67 |
Ryvu Therapeutics S.A. | 9Y4 | May 31, 2024 | 12.34 | +2.32 |
Sareum Holdings Plc | RYH0 | May 31, 2024 | 0.46 | -2.53 |
Scancell Hldgs Plc | SCP | May 31, 2024 | 0.10 | 0.00 |
Sensorion | RFM | May 31, 2024 | 0.74 | -6.33 |
Shanghai Haohai Biological Technology Co. Ltd | 5HB | May 31, 2024 | 4.98 | +4.62 |
Silence Therapeutics Plc - American Depository Share | XRP2 | May 31, 2024 | 19.20 | +1.59 |
Simcere Pharmaceutical Group Limited | S2P | May 31, 2024 | 0.67 | +0.75 |
SINO BIOPHARM | SMZ1 | May 31, 2024 | 0.33 | +1.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.